Are you looking for a partner to support all phases of clinical development? Discover Syngene's extensive range of Clinical Laboratory and Bioanalytical services designed to support all phases of clinical development. Our capabilities include: -Bioanalytical Laboratory for Biologics: GLP-certified, specializing in PK, PD, and immunogenicity of biotherapeutics. -Bioanalytical Laboratory for Small Molecules: Method development, validation, bioanalysis for TDM, BA/BE, and PK studies. -Central Laboratory: CAP-accredited, offering clinical study support, assay development, and biomarker services. Our state-of-the-art integrated solutions and facilities provide high-quality, reliable, and innovative services tailored to meet your clinical development needs from early-phase trials to commercialization. Get in touch with our experts today 👉 https://lnkd.in/gRbdAmit #ClinicalTrials #ClinicalDevelopment #Syngene
Syngene International Limited’s Post
More Relevant Posts
-
Industrial Pharmacy at International Pharmaceutical Federation (FIP)
📍A new #webinar will be organised by FIP Industrial Pharmacy Section on 24th September 2024, 3pm CET, with the topic: "Artificial Intelligence for the Design of New RNA Nanocarriers''. Our speaker will be Olivia Merkel, Professor of Drug Delivery Ludwig Maximillian University (LMU), Munich, Germany. Read more details and secure your attendance by *registering* via the link below 👇 https://lnkd.in/eCCdvZhT After participating in this webinar, attendees will be able to : 1) Understand what the current barriers for RNA therapeutics are 2) Learn how artificial intelligence can speed up the search for better RNA nanocarriers International Pharmaceutical Federation (FIP) #fipdigitalevents #fip #pharmacy
-
-
Innovation to Commercialization, advancing therapeutics by enabling drug manufacturing processes
GMP manufacturing of RNA-LNPs is both labor intensive and resource heavy, posing new challenges as RNA therapeutics expand to new applications and diverse scales. Join our @GEN webinar to learn strategies for successfully navigating evolving manufacturing workflows for RNA-LNP drug development: https://lnkd.in/eCv-2ggy #mRNA #LNPs
-
Recent FDA approvals for new drugs targeting complement proteins means there has never been greater momentum than now in the development of new complement therapeutics. At Kypha we have long recognized how much potential remains untapped in the complement space. With our expertise in measuring these molecules and our purpose-built complement biomarker platform, we are well positioned to help small biotech and large pharma capitalize on this renewed focus on the complement pathway. To find out more about our complement expertise, visit https://lnkd.in/eXvm62xD #complement #complementdiagnostics #complementtherapeutics #immunemonitoring #diagnostics #immunediagnostics
-
-
Enabling Researchers Developing Innovative Vaccines, Biologic Drugs, and Novel Cell and Gene Therapies
GMP manufacturing of RNA-LNPs is both labor intensive and resource heavy, posing new challenges as RNA therapeutics expand to new applications and diverse scales. Join our @GEN webinar to learn strategies for successfully navigating evolving manufacturing workflows for RNA-LNP drug development: https://lnkd.in/eXZrsaVv #mRNA #LNPs
-
🔬 Driving Breakthroughs in Molecular Interaction Analysis | Empowering Life Science Discoveries with Label-Free Technology | 🧪 🧬
GMP manufacturing of RNA-LNPs is both labor intensive and resource heavy, posing new challenges as RNA therapeutics expand to new applications and diverse scales. Join our @GEN webinar to learn strategies for successfully navigating evolving manufacturing workflows for RNA-LNP drug development: https://lnkd.in/gP3smbJX #mRNA #LNPs
-
Discovery Medical Sales Account Manager at Cytiva | Boston West & South | Platinum Sales Club-Rookie of the Year Award 2020
GMP manufacturing of RNA-LNPs is both labor intensive and resource heavy, posing new challenges as RNA therapeutics expand to new applications and diverse scales. Join our @GEN webinar to learn strategies for successfully navigating evolving manufacturing workflows for RNA-LNP drug development: https://lnkd.in/ejXgr4MT #mRNA #LNPs
-
Join industry experts in bioanalysis as they share how to resolve some common challenges in #bioanalytical development of #biologics and #cellandgenetherapies. Register now!
It's not too late to register for PBSS International #workshop on #bioanalysis for #biologics and #cellandgenetherapies. Explore pharmacokinetic and immunogenicity assessments, evolving regulatory frameworks, and their implications for drug development, while gaining practical insights from case studies and innovative strategies in complex-modality bioanalysis. What: "Current State of Bioanalysis for Biologics and Cell/Gene Therapy Products: Refining Established Approaches for New Complex Therapies" When: November 15, 8:45 am - 5:20 pm PT Who: Sebastian Guelman, Genentech; Jintang He, Genentech; Stephanie Pasas Farmer, PhD, BioData Solutions; Kelly Colletti, Beam Therapeutics; Surinder Kaur, Ph.D., Genentech; Bob Liu, Genentech Where: In-person at Crowne Plaza Foster City, CA or virtually via a webcast Register at: https://lnkd.in/gYbXcnVJ
-
GMP manufacturing of RNA-LNPs is both labor intensive and resource heavy, posing new challenges as RNA therapeutics expand to new applications and diverse scales. Join our @GEN webinar to learn strategies for successfully navigating evolving manufacturing workflows for RNA-LNP drug development: https://lnkd.in/gryna6XJ #mRNA #LNPs
-
GMP manufacturing of RNA-LNPs is both labor intensive and resource heavy, posing new challenges as RNA therapeutics expand to new applications and diverse scales. Join our @GEN webinar to learn strategies for successfully navigating evolving manufacturing workflows for RNA-LNP drug development: https://lnkd.in/evPzYw39 #mRNA #LNPs
-
Come see us during Day 2 of Festival of Biologics! Today we have a talk at 12:55 pm in Room 11a, presented by our Founder & CEO, Dr. Bharath Takulapalli. And stop by poster 60 this evening at 6:10 pm to learn more about how SPOC can assist your AI-designed antibody-based therapeutic drug discovery! We will also be at booth S6 in the start-up zone all day! #SPOCProteomics #ProteinKineticsAtScale #KineticProteomics #drugdiscovery #antibodytherapeutics #aidrugdiscovery #FestivalofBiologicsUSA
-
